Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    axitinib (Inlyta) and pembrolizumab
Previous Study | Return to List | Next Study

Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02636725
Recruitment Status : Active, not recruiting
First Posted : December 22, 2015
Last Update Posted : July 1, 2019
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Pfizer
Information provided by (Responsible Party):
Matteo Trucco, MD, University of Miami